These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

821 related items for PubMed ID: 19828639

  • 1. Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits.
    Boullier S, Tanguy M, Kadaoui KA, Caubet C, Sansonetti P, Corthésy B, Phalipon A.
    J Immunol; 2009 Nov 01; 183(9):5879-85. PubMed ID: 19828639
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Secretory immunoglobulin A: well beyond immune exclusion at mucosal surfaces.
    Corthësy B.
    Immunopharmacol Immunotoxicol; 2009 Jun 01; 31(2):174-9. PubMed ID: 19514992
    [Abstract] [Full Text] [Related]

  • 5. SIgA-Shigella Immune Complexes Interact with Dectin-1 and SIGNR3 to Differentially Regulate Mouse Peyer's Patch and Mesenteric Lymph Node Dendritic Cell's Responsiveness.
    Mikulic J, Bioley G, Corthésy B.
    J Mol Biol; 2017 Jul 21; 429(15):2387-2400. PubMed ID: 28587925
    [Abstract] [Full Text] [Related]

  • 6. Rupture of the intestinal epithelial barrier and mucosal invasion by Shigella flexneri.
    Sansonetti PJ, Tran Van Nhieu G, Egile C.
    Clin Infect Dis; 1999 Mar 21; 28(3):466-75. PubMed ID: 10194063
    [Abstract] [Full Text] [Related]

  • 7. Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium.
    D'Hauteville H, Khan S, Maskell DJ, Kussak A, Weintraub A, Mathison J, Ulevitch RJ, Wuscher N, Parsot C, Sansonetti PJ.
    J Immunol; 2002 May 15; 168(10):5240-51. PubMed ID: 11994481
    [Abstract] [Full Text] [Related]

  • 8. Blockade of CD14 aggravates experimental shigellosis.
    Wennerås C, Ave P, Huerre M, Arondel J, Ulevitch R, Mathison J, Sansonetti P.
    J Endotoxin Res; 2001 May 15; 7(6):442-6. PubMed ID: 11753214
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of interleukin-1 in the pathogenesis of experimental shigellosis.
    Sansonetti PJ, Arondel J, Cavaillon JM, Huerre M.
    J Clin Invest; 1995 Aug 15; 96(2):884-92. PubMed ID: 7635983
    [Abstract] [Full Text] [Related]

  • 14. Stereotypic and specific elements of the human colonic response to Entamoeba histolytica and Shigella flexneri.
    Zhang Z, Stanley SL.
    Cell Microbiol; 2004 Jun 15; 6(6):535-54. PubMed ID: 15104595
    [Abstract] [Full Text] [Related]

  • 15. Neuromodulation of experimental Shigella infection reduces damage to the gut mucosa.
    Svensson L, Bergquist J, Wennerås C.
    Microbes Infect; 2004 Mar 15; 6(3):256-64. PubMed ID: 15026012
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Targeting of secretory IgA to Peyer's patch dendritic and T cells after transport by intestinal M cells.
    Rey J, Garin N, Spertini F, Corthésy B.
    J Immunol; 2004 Mar 01; 172(5):3026-33. PubMed ID: 14978107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.